Not known Factual Statements About sodium pentobarbital pentobarbital
Not known Factual Statements About sodium pentobarbital pentobarbital
Blog Article
pentobarbital will reduce the extent or effect of mestranol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.
pentobarbital will lessen the extent or effect of oxybutynin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Unidentified.
Contraindicated (one)pentobarbital will minimize the extent or effect of lumacaftor/ivacaftor by affecting hepatic/intestinal enzyme CYP3A4 metabolism.
Pediatric neurotoxicity: Posted animal research exhibit that the administration of anesthetic and sedation drugs that block NMDA receptors and/or potentiate GABA exercise maximize neuronal apoptosis inside the building brain and cause very long-time period cognitive deficits when used for extended than 3 hours. The scientific importance of those conclusions is not distinct. On the other hand, based within the offered facts, the window of vulnerability to these adjustments is considered to correlate with exposures during the third trimester of gestation in the 1st many months of life, but may well extend out to close to a few several years of age in humans (see “Precautions-Pregnancy and Pediatric Use” and “Animal Pharmacology and/or Toxicology”).
buprenorphine transdermal and pentobarbital both boost sedation. Stay clear of or Use Alternate Drug. Restrict use to people for whom alternative therapy possibilities are inadequate
pentobarbital will decrease the level or effect of armodafinil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Not known.
pentobarbital will reduce the level or effect of triamcinolone acetonide injectable suspension by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
pentobarbital will decrease the extent or effect of sufentanil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Slight/Importance Unknown.
pentobarbital read more will lower the level or effect of nicardipine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
Corticosteroids: Barbiturates appear to reinforce the metabolism of exogenous corticosteroids most likely from the induction of hepatic microsomal enzymes. Patients stabilized on corticosteroid therapy may well involve dosage adjustments if barbiturates are additional to or withdrawn from their dosage routine.
pentobarbital will decrease the extent or effect of rolapitant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Keep away from or Use Alternate Drug. Very long-expression coadministration of solid CYP3A4 inducers with rolapitant may well noticeably minimize rolapitant efficacy.
pentobarbital will lessen the extent or effect of clarithromycin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Unknown.
pentobarbital will decrease the level or effect of conivaptan by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.
pentobarbital will lessen the extent or effect of imatinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Unfamiliar.